| Management number | 238699526 | Release Date | 2026/07/11 | List Price | $8.00 | Model Number | 238699526 | ||
|---|---|---|---|---|---|---|---|---|---|
| Category | |||||||||
<p>It started with the poles.<br>In the spring of 2046, both the Arctic and Antarctic ice shelves fractured within weeks of each other. Satellite footage showed massive collapses-serrated ice sheets falling into the oceans like glass. But this wasn't just a climate disaster. It was biological.</p><p>Dormant pathogens, ancient microbes, and cryptic viral reservoirs-entombed for tens of thousands of years-were suddenly released into the global ecosystem. The virosphere shifted. DNA once locked in permafrost seeped into our waters, our food, our bloodlines.</p><p>Among the survivors of that molecular resurrection was a mutated strain of <b>Epstein-Barr virus</b>. It wasn't just persistent-it was transformative, hijacking <b>B cells</b> in ways never before seen, catalyzing autoimmune activation at scale. Across continents, young adults began experiencing sudden neural decline-blurred vision, muscle stiffness, balance loss, and crushing fatigue. MRI scans revealed <b>demyelination</b> everywhere: brainstem, spinal cord, optic tracts. CSF showed <b>oligoclonal bands</b>. No classic MS medication worked-not even the latest monoclonals or B-cell depleters.</p><p>This was no longer the relapsing-remitting disease we once understood.<br><b>This was something else.</b></p><p>It was <b>MS, evolved</b>.</p><p>It spread rapidly. Not contagious by air, but by <b>genetics</b> and <b>latent viral reactivation</b>. Individuals with <b>HLA-DRB1</b> susceptibility, those previously infected with classic EBV, and those living at higher latitudes-everyone we once considered "moderate risk"-began showing aggressive neuroimmune responses. Within months, disability rates doubled. Mortality rose. Hospitals were overwhelmed not by stroke or heart failure, but by neurodegenerative collapse.</p><p>A new term entered the lexicon: <b>RRMS-X</b> - <i>Relapsing-Remitting Multiple Sclerosis, eXtended variant</i>.<br>But the truth was worse.<br><b>This version did not remit.</b></p><p>By late 2047, autopsies revealed a horrifying pattern: <b>oligodendrocyte death</b> not only in plaques, but in tissue never touched before-<b>cerebellar grey matter</b>, <b>hypothalamus</b>, <b>cervical spine</b>. It wasn't just inflammation. It was a <b>rewiring of the immune system</b>-targeting myelin as if it were a virus.</p><p>Every existing therapy-<b>dimethyl fumarate</b>, <b>ocrelizumab</b>, even <b>hematopoietic stem cell transplantation</b>-failed. They couldn't suppress what had become <b>hard-coded into the immune memory</b>.</p><p>Governments responded with funding. Corporations chased patents.<br><b>Nothing slowed the progression.</b></p><p>The cure was never going to be one pill, one procedure, or one injection.<br>It would take a <b>system of systems</b>-<b>genetic correction</b>, <b>nanoscaffold regeneration</b>, <b>cellular reprogramming&am</b></p>
| Book format | Paperback |
|---|---|
| Fiction/nonfiction | Fiction |
| Genre | Literature & Fiction |
| Publication date | July, 2025 |
| Pages | 42 |
| Subgenre | Science Fiction |
| Edition | 1 |
| Publisher | Amazon Digital Services LLC - Kdp |
| Language | English |
| Is collectible | N |
| Retail packaging | Single Piece |
| Assembled product dimensions (l x w x h) | 6.00 x 0.11 x 9.00 in |
| Assembled product weight | 0.2 lb |
| Bisac subject heading | Fiction |
If you notice any omissions or errors in the product information on this page, please use the correction request form below.
Correction Request Form